A recall has been issued for a blood pressure medication due to a mix-up that might have resulted in some bottles containing the incorrect drug.
As reported by Health Canada, Marcan Pharmaceuticals Inc. has withdrawn two batches of MAR-Amlodipine 5 milligram tablets, which are intended for managing high blood pressure and alleviating chest pain.
This action was taken because it appears that some bottles may contain 2.5 milligram tablets of midodrine, a medication prescribed for low blood pressure.
Patients can verify if they have received the wrong medication by examining the tablets.
The 5 milligram MAR-Amlodipine tablets are characterized as white or off-white, flat, and octagonal, featuring a line down the center and the numbers 210 and 5 on one side.
In contrast, the midodrine 2.5 milligram tablets are white, round, marked with M2 on one side, and have a line across the middle on the opposite side.
‘Potential serious side effects’
Health Canada advises that patients should return any bottles containing the round tablets to their pharmacy to obtain a replacement.
In accordance with its public advisory, replacing amlodipine with midodrine “can result in serious side effects including dangerously elevated blood pressure, dizziness, fainting, and potential organ damage.”
Individuals experiencing dizziness, unusually high blood pressure, or slow heart rates are urged to contact a healthcare professional or dial 911.
Health Canada further emphasizes that anyone suffering from chest pain, sudden headaches, impaired speech, or an inability to move or feel any part of their body should seek immediate medical assistance.
Tag: rewrite-pending

